Israel: Francis to take up CEO role at Teva in January

Teva Pharmaceutical Industries has appointed Richard Francis as president and CEO, effective January 1, 2023. He replaces Kåre Schultz who will retire effective December 31, 2022, following 17 years as Teva CEO. Francis, a seasoned pharmaceutical executive, brings more than two and a half decades of experience to Teva, including five years as CEO of…

You must be a HMI Subscriber to view this content.

Subscribe Now »